These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24787441)

  • 21. Scalable Synthesis of Biodegradable Black Mesoporous Silicon Nanoparticles for Highly Efficient Photothermal Therapy.
    Xu W; Tamarov K; Fan L; Granroth S; Rantanen J; Nissinen T; Peräniemi S; Uski O; Hirvonen MR; Lehto VP
    ACS Appl Mater Interfaces; 2018 Jul; 10(28):23529-23538. PubMed ID: 29905461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.
    Korhonen E; Rönkkö S; Hillebrand S; Riikonen J; Xu W; Järvinen K; Lehto VP; Kauppinen A
    Eur J Pharm Biopharm; 2016 Mar; 100():1-8. PubMed ID: 26686646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles.
    Liu D; Bimbo LM; Mäkilä E; Villanova F; Kaasalainen M; Herranz-Blanco B; Caramella CM; Lehto VP; Salonen J; Herzig KH; Hirvonen J; Santos HA
    J Control Release; 2013 Sep; 170(2):268-78. PubMed ID: 23756152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application.
    Chen L; Zhang S; Duan Y; Song X; Chang M; Feng W; Chen Y
    Chem Soc Rev; 2024 Feb; 53(3):1167-1315. PubMed ID: 38168612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional nanoparticles for multimodal imaging and theragnosis.
    Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC
    Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodality Imaging of Silica and Silicon Materials In Vivo.
    Karaman DŞ; Sarparanta MP; Rosenholm JM; Airaksinen AJ
    Adv Mater; 2018 Jun; 30(24):e1703651. PubMed ID: 29388264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the mechanisms of silica nanoparticles for nanomedicine.
    Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porous silicon: a resourceful material for nanotechnology.
    Betty CA
    Recent Pat Nanotechnol; 2008; 2(2):128-36. PubMed ID: 19076047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
    Shrestha N; Shahbazi MA; Araújo F; Zhang H; Mäkilä EM; Kauppila J; Sarmento B; Salonen JJ; Hirvonen JT; Santos HA
    Biomaterials; 2014 Aug; 35(25):7172-9. PubMed ID: 24844163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo.
    Lane LA; Qian X; Smith AM; Nie S
    Annu Rev Phys Chem; 2015 Apr; 66():521-47. PubMed ID: 25622189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
    Castillo RR; Baeza A; Vallet-Regí M
    Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The advanced role of carbon quantum dots in nanomedical applications.
    Devi P; Saini S; Kim KH
    Biosens Bioelectron; 2019 Sep; 141():111158. PubMed ID: 31323605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional porous silicon nanoparticles for cancer theranostics.
    Wang CF; Sarparanta MP; Mäkilä EM; Hyvönen ML; Laakkonen PM; Salonen JJ; Hirvonen JT; Airaksinen AJ; Santos HA
    Biomaterials; 2015 Apr; 48():108-18. PubMed ID: 25701036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.